Clinical Trial Update: Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating olanzapine for chemotherapy-induced nausea and vomiting prophylaxis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Complete Response Rate to Chemotherapy-induced Nausea and Vomiting Prophylaxis | Phase 3 | Status: COMPLETED